Remus Vezan
National University of Misiones(AR)Clinical Solutions(US)Universidad San Carlos(PY)
Publications by Year
Research Areas
CAR-T cell therapy research, Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Acute Lymphoblastic Leukemia research, Phagocytosis and Immune Regulation
Most-Cited Works
- → KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study(2021)737 cited
- → Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial(2021)589 cited
- → Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab(2019)240 cited
- → KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results(2021)192 cited
- → Primary Analysis of Zuma-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)(2020)107 cited
- → Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study(2017)94 cited